PRIYANKA JINDAL: Open Payments
NPI 1457721235 · SHARON HILL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,187 in 108 payments from 10 companies in 2025. Trend: 2023 $855 · 2024 $1,228 · 2025 $2,187
Food & beverage: $2,187
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 39 | $734 |
| ViiV Healthcare Company | 31 | $597 |
| ABBVIE INC. | 19 | $412 |
| Theratechnologies Inc. | 5 | $141 |
| Merck Sharp & Dohme LLC | 4 | $98 |
| Napo Pharmaceuticals Inc | 4 | $80 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Braeburn Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: VRAYLAR, DOVATO, EGRIFTA, RUKOBIA, PIFELTRO, Biktarvy, Mytesi, APRETUDE.
Industry payments across PA — which companies pay providers there.
